Unique Cheek-filling Agent Juvederm Voluma gets FDA approval
If sagging, hollow cheeks have got you down, here’s some good news: The U.S. Food and Drug Administration has given the final go-ahead for Allergan’s revolutionizing new filler Juvéderm Voluma XC (Voluma for short), a product designed to put apples back in patients’ cheeks and restore a more youthful fullness to the midface region. Although several fillers have been approved for use in those pesky smile lines (a.k.a., nasalabial folds) that extend from the nose to the sides of the mouth, Voluma is the first filler to be approved by the FDA for use in correcting volume loss in the cheeks which can be the culprit of the sagginess in the jowl. By correcting the volume loss in the midface, the jowl will be uplifted as well.
For the past five years, Voluma has been undergoing pre-approval studies in the U.S., so its approval is especially good news for both cosmetic surgeons and patients. Already widely in use overseas, Voluma uses hyaluronic acid via Vycross technology, a substance that occurs naturally in the body, to achieve fullness in the cheeks. Other products – including “traditional” Juvederm Ultra – use hyaluronic acid, but this is the first product FDA approved for deeper injections required to restore fullness in the cheeks.
The cheek area is one of the first areas of the face to show the effects of volume loss, resulting in sagging or droopy-looking skin and a hollowed-out appearance that can add years to your age. Juvederm Voluma gel contains lidocaine, a mild anesthetic to decrease discomfort, making it ideal for deeper injections directly over the cheekbones. Voluma also offers another benefit: Study results indicate injection results last for as long as two years, meaning there’s less likelihood of frequent refills.
Study results report mild side effects, including mild tenderness, bruising, redness or other discoloration, swelling, bumps or lumps under the skin, and temporary itching. Offering great results and few side effects, the primary deterrent right now may be the price: A single 1-cc syringe is about $1,000, with most patients requiring one to four syringes to get the desired results. Given the long-lasting results and the aesthetic benefits, many patients will consider that a price worth paying.
For more information contact Laser Clinique at (858)481-7701. P. Alexander Ataii M.D. has provided over 15,000 Botox treatments, as well as over 5,000 injectable fillers. He is considered one of the foremost authorities in non-surgical facial rejuvenation.